FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to roentgenology, oncology and pulmonology, and can be used as a screening method of lung cancer. Method for lung cancer screening using ultra-low-dose computed tomography in patients with body weight of 70 to 89 kg comprises the following stages: scanning is carried out in a patient's position on the back with hands drawn to the head; scanning is performed with breath holding at inhalation depth; scanning length from apexes of lungs to pulmonary sinuses is established; filter is installed for lung examination. Voltage is set on 135 kV tube (kv); setting current on tube (mA) 20 mA; computer tomographic dose index (CTDI) 1.0 mGy; setting the rotation speed of the tube (Time rotation) 0.50 sec.
EFFECT: using the given invention enables reducing the dose of the radiation load on the patient.
3 cl, 6 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SCREENING LUNG CANCER BY ULTRA-LOW-DOSE COMPUTED TOMOGRAPHY IN PATIENTS WITH BODY WEIGHT OF MORE THAN 90 KG | 2020 |
|
RU2741707C1 |
METHOD FOR LUNG CANCER SCREENING USING ULTRA-LOW-DOSE COMPUTED TOMOGRAPHY IN PATIENTS WITH BODY WEIGHT OF UP TO 69 KG | 2018 |
|
RU2701922C1 |
METHOD FOR LOW-DOSE SCANNING OF CHEST ORGANS, ADAPTED TO PATIENT'S BODY WEIGHT | 2020 |
|
RU2753474C1 |
METHOD FOR DIAGNOSING MALIGNANT TUMORS OF THORACIC CAVITY ORGANS | 2023 |
|
RU2817246C1 |
METHOD OF EXAMINING THE STATE OF THE LUNGS WITH SUSPECTED COVID-19 USING LOW-DOSE COMPUTED TOMOGRAPHY | 2020 |
|
RU2744552C1 |
METHOD OF VISUALISING INTERNAL ORGANS IN CASE OF SEVERE INJURY IN CHILDREN | 2012 |
|
RU2504333C1 |
METHOD FOR PERFUSION COMPUTED TOMOGRAPHY OF LUNGS IN DIFFERENTIAL DIAGNOSIS OF CONSOLIDATED PULMONARY TISSUE | 2024 |
|
RU2825590C1 |
METHOD FOR MAGNETIC RESONANCE IMAGING OF THE PROSTATE GLAND IN PATIENTS WITH METAL STRUCTURES OF THE HIP JOINT | 2021 |
|
RU2783002C1 |
METHOD FOR DIAGNOSTICS OF EXAMINATION OF SARCOIDOSIS | 2023 |
|
RU2795365C1 |
METHOD FOR TREATING PATIENTS WITH HIV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES WITH MODERATE AND SEVERE COVID-19 | 2022 |
|
RU2793414C1 |
Authors
Dates
2021-01-28—Published
2020-01-15—Filed